GAM Holding AG Sells 17,226 Shares of CME Group Inc. (CME)
GAM Holding AG cut its position in CME Group Inc. (NASDAQ:CME) by 24.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 54,052 shares of the company’s stock after selling 17,226 shares during the period. GAM Holding AG’s holdings in CME Group were worth $5,650,000 as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. Gofen & Glossberg LLC IL increased its position in shares of CME Group by 0.4% in the second quarter. Gofen & Glossberg LLC IL now owns 7,323 shares of the company’s stock worth $713,000 after buying an additional 26 shares during the last quarter. Capstone Asset Management Co. raised its stake in shares of CME Group by 4.9% in the second quarter. Capstone Asset Management Co. now owns 29,334 shares of the company’s stock worth $2,857,000 after buying an additional 1,372 shares during the period. NN Investment Partners Holdings N.V. raised its stake in shares of CME Group by 4.5% in the second quarter. NN Investment Partners Holdings N.V. now owns 16,325 shares of the company’s stock worth $1,590,000 after buying an additional 700 shares during the period. Beacon Financial Group raised its stake in shares of CME Group by 0.8% in the second quarter. Beacon Financial Group now owns 4,525 shares of the company’s stock worth $435,000 after buying an additional 38 shares during the period. Finally, Hefty Wealth Partners raised its stake in shares of CME Group by 8.6% in the second quarter. Hefty Wealth Partners now owns 8,573 shares of the company’s stock worth $835,000 after buying an additional 680 shares during the period. 79.55% of the stock is owned by institutional investors.
Shares of CME Group Inc. (NASDAQ:CME) traded up 0.737% during mid-day trading on Tuesday, hitting $112.705. 728,556 shares of the stock were exchanged. CME Group Inc. has a one year low of $81.87 and a one year high of $117.80. The stock has a market cap of $38.25 billion, a PE ratio of 26.272 and a beta of 0.81. The company has a 50-day moving average of $107.19 and a 200 day moving average of $102.98.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, October 27th. The company reported $1.05 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.01. The firm had revenue of $842 million for the quarter, compared to the consensus estimate of $855.94 million. CME Group had a net margin of 41.54% and a return on equity of 6.90%. The firm’s revenue was down 1.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.02 earnings per share. On average, equities analysts predict that CME Group Inc. will post $4.35 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 28th. Investors of record on Friday, December 9th will be issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 2.15%. The ex-dividend date is Wednesday, December 7th. CME Group’s dividend payout ratio is currently 55.94%.
Several equities research analysts have commented on CME shares. Deutsche Bank AG upped their price target on shares of CME Group from $111.00 to $112.00 and gave the company a “buy” rating in a report on Friday, August 5th. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $116.00 price target on the stock in a report on Thursday, August 4th. JPMorgan Chase & Co. lowered shares of CME Group from an “overweight” rating to a “neutral” rating and set a $116.00 price target on the stock. in a report on Monday, November 14th. They noted that the move was a valuation call. RBC Capital Markets set a $92.00 price target on shares of CME Group and gave the company a “sell” rating in a report on Friday, October 28th. Finally, Jefferies Group reaffirmed a “buy” rating and issued a $118.00 price target on shares of CME Group in a report on Thursday, October 13th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. CME Group has an average rating of “Hold” and an average price target of $102.89.
In other CME Group news, insider Bryan T. Durkin sold 15,000 shares of the company’s stock in a transaction dated Tuesday, September 6th. The shares were sold at an average price of $107.75, for a total value of $1,616,250.00. Following the sale, the insider now owns 63,967 shares of the company’s stock, valued at $6,892,444.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Bryan T. Durkin sold 14,990 shares of the company’s stock in a transaction dated Wednesday, September 28th. The shares were sold at an average price of $105.10, for a total transaction of $1,575,449.00. Following the completion of the sale, the insider now directly owns 66,936 shares in the company, valued at approximately $7,034,973.60. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by company insiders.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.